SEARCH

SEARCH BY CITATION

References

  • Algara, P., Mateo, M.S., Sanchez-Beato, M., Mollejo, M., Navas, I.C., Romero, L., Sole, F., Salido, M., Florensa, L., Martinez, P., Campo, E. & Piris, M.A. (2002) Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course. Blood, 99, 12991304.
  • Barde, I., Zanta-Boussif, M.A., Paisant, S., Leboeuf, M., Rameau, P., Delenda, C. & Danos, O. (2006) Efficient control of gene expression in the hematopoietic system using a single Tet-on inducible lentiviral vector. Molecular Therapy, 13, 382390.
  • Barnes, B.J., Kellum, M.J., Pinder, K.E., Frisancho, J.A. & Pitha, P.M. (2003) Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death. Cancer Research, 63, 64246431.
  • Beltran, E., Fresquet, V., Martinez-Useros, J., Richter-Larrea, J.A., Sagardoy, A., Sesma, I., Almada, L.L., Montes-Moreno, S., Siebert, R., Gesk, S., Calasanz, M.J., Malumbres, R., Rieger, M., Prosper, F., Lossos, I.S., Piris, M.A., Fernandez-Zapico, M.E. & Martinez-Climent, J.A. (2011) A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America, 108, 1246112466.
  • Bowne, S.J., Sullivan, L.S., Mortimer, S.E., Hedstrom, L., Zhu, J., Spellicy, C.J., Gire, A.I., Hughbanks-Wheaton, D., Birch, D.G., Lewis, R.A., Heckenlively, J.R. & Daiger, S.P. (2006) Spectrum and frequency of mutations in IMPDH1 associated with autosomal dominant retinitis pigmentosa and leber congenital amaurosis. Investigative Ophthalmology & Visual Science, 47, 3442.
  • Burda, P., Laslo, P. & Stopka, T. (2010) The role of PU.1 and GATA-1 transcription factors during normal and leukemogenic hematopoiesis. Leukemia, 24, 12491257.
  • Camacho, F.I., Mollejo, M., Mateo, M.S., Algara, P., Navas, C., Hernandez, J.M., Santoja, C., Sole, F., Sanchez-Beato, M. & Piris, M.A. (2001) Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases. American Journal of Surgical Pathology, 25, 12681276.
  • Campo, E., Swerdlow, S.H., Harris, N.L., Pileri, S., Stein, H. & Jaffe, E.S. (2011) The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood, 117, 50195032.
  • Catovsky, D. & Matutes, E. (1999) Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma. Seminars in Hematology, 36, 148154.
  • Corcoran, M.M., Mould, S.J., Orchard, J.A., Ibbotson, R.E., Chapman, R.M., Boright, A.P., Platt, C., Tsui, L.C., Scherer, S.W. & Oscier, D.G. (1999) Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations. Oncogene, 18, 62716277.
  • Daibata, M., Taguchi, T., Nemoto, Y., Iwasaki, S., Ohtsuki, Y. & Taguchi, H. (2006) In vitro Epstein-Barr virus-immortalized lymphoma cell line carrying t(9;14)(p13;q32) chromosome abnormality, derived from splenic lymphoma with villous lymphocytes. International Journal of Cancer, 118, 513517.
  • Dawidowicz, K., Allanore, Y., Guedj, M., Pierlot, C., Bombardieri, S., Balsa, A., Westhovens, R., Barrera, P., Alves, H., Teixeira, V.H., Petit-Teixeira, E., van de Putte, L., van Riel, P., Prum, B., Bardin, T., Meyer, O., Cornelis, F. & Dieude, P. (2011) The interferon regulatory factor 5 gene confers susceptibility to rheumatoid arthritis and influences its erosive phenotype. Annals of the Rheumatic Diseases, 70, 117121.
  • Duff, R.M., Tay, V., Hackman, P., Ravenscroft, G., McLean, C., Kennedy, P., Steinbach, A., Schoffler, W., van der Ven, P.F., Furst, D.O., Song, J., Djinovic-Carugo, K., Penttila, S., Raheem, O., Reardon, K., Malandrini, A., Gambelli, S., Villanova, M., Nowak, K.J., Williams, D.R., Landers, J.E., Brown, R.H., Jr, Udd, B. & Laing, N.G. (2011) Mutations in the N-terminal actin-binding domain of filamin C cause a distal myopathy. American Journal of Human Genetics, 88, 729740.
  • Fitzgibbon, J., Smith, L.L., Raghavan, M., Smith, M.L., Debernardi, S., Skoulakis, S., Lillington, D., Lister, T.A. & Young, B.D. (2005) Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias. Cancer Research, 65, 91529154.
  • Graham, R.R., Kozyrev, S.V., Baechler, E.C., Reddy, M.V., Plenge, R.M., Bauer, J.W., Ortmann, W.A., Koeuth, T., Gonzalez Escribano, M.F., Pons-Estel, B., Petri, M., Daly, M., Gregersen, P.K., Martin, J., Altshuler, D., Behrens, T.W. & Alarcon-Riquelme, M.E. (2006) A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nature Genetics, 38, 550555.
  • Gruszka-Westwood, A.M., Hamoudi, R., Osborne, L., Matutes, E. & Catovsky, D. (2003) Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes. Genes Chromosomes Cancer, 36, 5769.
  • Hermine, O., Lefrere, F., Bronowicki, J.P., Mariette, X., Jondeau, K., Eclache-Saudreau, V., Delmas, B., Valensi, F., Cacoub, P., Brechot, C., Varet, B. & Troussard, X. (2002) Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. New England Journal of Medicine, 347, 8994.
  • Hernandez, J.M., Garcia, J.L., Gutierrez, N.C., Mollejo, M., Martinez-Climent, J.A., Flores, T., Gonzalez, M.B., Piris, M.A. & San Miguel, J.F. (2001) Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics. American Journal of Pathology, 158, 18431850.
  • Hu, G. & Barnes, B.J. (2009) IRF-5 is a mediator of the death receptor-induced apoptotic signaling pathway. Journal of Biological Chemistry, 284, 27672777.
  • Inokuchi, K., Abo, J., Takahashi, H., Miyake, K., Inokuchi, S., Dan, K. & Nomura, T. (1995) Establishment and characterization of a villous lymphoma cell line from splenic B-cell lymphoma. Leukemia Research, 19, 817822.
  • Isaacson, P.G., Matutes, E., Burke, M. & Catovsky, D. (1994) The histopathology of splenic lymphoma with villous lymphocytes. Blood, 84, 38283834.
  • Korvatska, O., Estes, A., Munson, J., Dawson, G., Bekris, L.M., Kohen, R., Yu, C.E., Schellenberg, G.D. & Raskind, W.H. (2011) Mutations in the TSGA14 gene in families with autism spectrum disorders. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 156B, 303311.
  • Li, H. & Durbin, R. (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics, 25, 17541760.
  • Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G. & Durbin, R. (2009) The Sequence Alignment/Map format and SAMtools. Bioinformatics, 25, 20782079.
  • Lien, C., Fang, C.M., Huso, D., Livak, F., Lu, R. & Pitha, P.M. (2010) Critical role of IRF-5 in regulation of B-cell differentiation. Proceedings of the National Academy of Sciences of the United States of America, 107, 46644668.
  • Martinez-Climent, J.A., Alizadeh, A.A., Segraves, R., Blesa, D., Rubio-Moscardo, F., Albertson, D.G., Garcia-Conde, J., Dyer, M.J., Levy, R., Pinkel, D. & Lossos, I.S. (2003) Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. Blood, 101, 31093117.
  • Mateo, M., Mollejo, M., Villuendas, R., Algara, P., Sanchez-Beato, M., Martinez, P. & Piris, M.A. (1999) 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma. American Journal of Pathology, 154, 15831589.
  • Mestre-Escorihuela, C., Rubio-Moscardo, F., Richter, J.A., Siebert, R., Climent, J., Fresquet, V., Beltran, E., Agirre, X., Marugan, I., Marin, M., Rosenwald, A., Sugimoto, K.J., Wheat, L.M., Karran, E.L., Garcia, J.F., Sanchez, L., Prosper, F., Staudt, L.M., Pinkel, D., Dyer, M.J. & Martinez-Climent, J.A. (2007) Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas. Blood, 109, 271280.
  • Mollejo, M., Menarguez, J., Lloret, E., Sanchez, A., Campo, E., Algara, P., Cristobal, E., Sanchez, E. & Piris, M.A. (1995) Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases. The American Journal of Surgical Pathology, 19, 11461157.
  • Mori, T., Anazawa, Y., Iiizumi, M., Fukuda, S., Nakamura, Y. & Arakawa, H. (2002) Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53. Oncogene, 21, 29142918.
  • Nielaender, I., Martin-Subero, J.I., Wagner, F., Martinez-Climent, J.A. & Siebert, R. (2006) Partial uniparental disomy: a recurrent genetic mechanism alternative to chromosomal deletion in malignant lymphoma. Leukemia, 20, 904905.
  • Oscier, D., Owen, R. & Johnson, S. (2005) Splenic marginal zone lymphoma. Blood Reviews, 19, 3951.
  • Remstein, E.D., Law, M., Mollejo, M., Piris, M.A., Kurtin, P.J. & Dogan, A. (2008) The prevalence of IG translocations and 7q32 deletions in splenic marginal zone lymphoma. Leukemia, 22, 12681272.
  • Richter-Larrea, J.A., Robles, E.F., Fresquet, V., Beltran, E., Rullan, A.J., Agirre, X., Calasanz, M.J., Panizo, C., Richter, J.A., Hernandez, J.M., Roman-Gomez, J., Prosper, F. & Martinez-Climent, J.A. (2010) Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma. Blood, 116, 25312542.
  • Rinaldi, A., Mian, M., Chigrinova, E., Arcaini, L., Bhagat, G., Novak, U., Rancoita, P.M., De Campos, C.P., Forconi, F., Gascoyne, R.D., Facchetti, F., Ponzoni, M., Govi, S., Ferreri, A.J., Mollejo, M., Piris, M.A., Baldini, L., Soulier, J., Thieblemont, C., Canzonieri, V., Gattei, V., Marasca, R., Franceschetti, S., Gaidano, G., Tucci, A., Uccella, S., Tibiletti, M.G., Dirnhofer, S., Tripodo, C., Doglioni, C., Dalla Favera, R., Cavalli, F., Zucca, E., Kwee, I. & Bertoni, F. (2011) Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood, 117, 15951604.
  • Rossi, D., Deaglio, S., Dominguez-Sola, D., Rasi, S., Vaisitti, T., Agostinelli, C., Spina, V., Bruscaggin, A., Monti, S., Cerri, M., Cresta, S., Fangazio, M., Arcaini, L., Lucioni, M., Marasca, R., Thieblemont, C., Capello, D., Facchetti, F., Kwee, I., Pileri, S.A., Foa, R., Bertoni, F., Dalla-Favera, R., Pasqualucci, L. & Gaidano, G. (2011) Alteration of BIRC3 and multiple other NF-kappaB pathway genes in splenic marginal zone lymphoma. Blood, 118, 49304934.
  • Rubio-Moscardo, F., Climent, J., Siebert, R., Piris, M.A., Martin-Subero, J.I., Nielander, I., Garcia-Conde, J., Dyer, M.J., Terol, M.J., Pinkel, D. & Martinez-Climent, J.A. (2005) Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome. Blood, 105, 44454454.
  • Salido, M., Baro, C., Oscier, D., Stamatopoulos, K., Dierlamm, J., Matutes, E., Traverse-Glehen, A., Berger, F., Felman, P., Thieblemont, C., Gesk, S., Athanasiadou, A., Davis, Z., Gardiner, A., Milla, F., Ferrer, A., Mollejo, M., Calasanz, M.J., Florensa, L., Espinet, B., Luno, E., Wlodarska, I., Verhoef, G., Garcia-Granero, M., Salar, A., Papadaki, T., Serrano, S., Piris, M.A. & Sole, F. (2010) Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group. Blood, 116, 14791488.
  • Sanchez-Izquierdo, D., Siebert, R., Harder, L., Marugan, I., Gozzetti, A., Price, H.P., Gesk, S., Hernandez-Rivas, J.M., Benet, I., Sole, F., Sonoki, T., Le Beau, M.M., Schlegelberger, B., Dyer, M.J., Garcia-Conde, J. & Martinez-Climent, J.A. (2001) Detection of translocations affecting the BCL6 locus in B cell non-Hodgkin's lymphoma by interphase fluorescence in situ hybridization. Leukemia, 15, 14751484.
  • Shin, S.H., Kim, B.H., Jang, J.J., Suh, K.S. & Kang, G.H. (2010) Identification of novel methylation markers in hepatocellular carcinoma using a methylation array. Journal of Korean Medical Science, 25, 11521159.
  • Smyth, G.K. (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Statistical Applications in Genetics and Molecular Biology, 3, Article3.
  • Sole, F., Salido, M., Espinet, B., Garcia, J.L., Martinez Climent, J.A., Granada, I., Hernandez, J.M., Benet, I., Piris, M.A., Mollejo, M., Martinez, P., Vallespi, T., Domingo, A., Serrano, S., Woessner, S. & Florensa, L. (2001) Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q. Haematologica, 86, 7177.
  • Thieblemont, C., Felman, P., Callet-Bauchu, E., Traverse-Glehen, A., Salles, G., Berger, F. & Coiffier, B. (2003) Splenic marginal-zone lymphoma: a distinct clinical and pathological entity. The Lancet Oncology, 4, 95103.
  • Vicente-Dueñas, C., Fontan, L., Gonzalez-Herrero, I., Romero-Camarero, I., Segura, V., Aznar, M.A., Alonso-Escudero, E., Campos-Sanchez, E., Ruiz-Roca, L., Barajas-Diego, M., Sagardoy, A., Martinez-Ferrandis, J.I, Abollo-Jimemez, F., Bertolgo, C., Peñuelas, I., Garcia-Criado, F.J., García-Cenador, M.B., Tousseyn, T., Agirre, X., Prosper, F., Garcia-Bragado, F., McPhail, E.D., Lossos, I.S., Du, M.Q., Flores, T., Hernandez-Rivas, J.M., Gonzalez, M., Salar, A., Bellosillo, B., Conde, E., Siebert, R., Sagaert, X., Cobaleda, C., Sanchez-Garcia, I. & Martinez-Climent, J.A. (2012) Expression of MALT1 oncogene in mouse hematopoietic stem/progenitor cells recapitulates the pathogenesis of human MALT lymphoma. Proceedings of the National Academy of Sciences of the United States of America, 109, 1053410539.
  • Watkins, A.J., Huang, Y., Ye, H., Chanudet, E., Johnson, N., Hamoudi, R., Liu, H., Dong, G., Attygalle, A., McPhail, E.D., Law, M.E., Isaacson, P.G., de Leval, L., Wotherspoon, A. & Du, M.Q. (2010) Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis. The Journal of pathology, 220, 461474.
  • Weller, S., Braun, M.C., Tan, B.K., Rosenwald, A., Cordier, C., Conley, M.E., Plebani, A., Kumararatne, D.S., Bonnet, D., Tournilhac, O., Tchernia, G., Steiniger, B., Staudt, L.M., Casanova, J.L., Reynaud, C.A. & Weill, J.C. (2004) Human blood IgM “memory” B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood, 104, 36473654.
  • Xu, D., Meyer, F., Ehlers, E., Blasnitz, L. & Zhang, L. (2011) Interferon regulatory factor 4 (IRF-4) targets IRF-5 to regulate Epstein-Barr virus transformation. Journal of Biological Chemistry, 286, 1826118267.
  • Yamashita, M., Toyota, M., Suzuki, H., Nojima, M., Yamamoto, E., Kamimae, S., Watanabe, Y., Kai, M., Akashi, H., Maruyama, R., Sasaki, Y., Yamano, H., Sugai, T., Shinomura, Y., Imai, K., Tokino, T. & Itoh, F. (2010) DNA methylation of interferon regulatory factors in gastric cancer and noncancerous gastric mucosae. Cancer Science, 101, 17081716.
  • Yang, L., Zhao, T., Shi, X., Nakhaei, P., Wang, Y., Sun, Q., Hiscott, J. & Lin, R. (2009) Functional analysis of a dominant negative mutation of interferon regulatory factor 5. PLoS ONE, 4, e5500.
  • Zhu, D., Orchard, J., Oscier, D.G., Wright, D.H. & Stevenson, F.K. (2002) V(H) gene analysis of splenic marginal zone lymphomas reveals diversity in mutational status and initiation of somatic mutation in vivo. Blood, 100, 26592661.